James C Blair's Net Worth

-$114 Thousand

Who is James C Blair?

James C Blair does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, Aldeyra Therapeutics, Inc., Syndax Pharmaceuticals Inc, Bionano Genomics, Inc., aTYR PHARMA INC, Neothetics, Inc., Durata Therapeutics, Inc., Ocera Therapeutics, Inc., Dicerna Pharmaceuticals Inc, Volcano Corp, Orexigen Therapeutics, Inc., ZOGENIX, INC., CoLucid Pharmaceuticals, Inc., TANDEM DIABETES CARE INC, VERACYTE, INC., Atara Biotherapeutics, Inc., Vanda Pharmaceuticals Inc., Esperion Therapeutics, Inc., Clovis Oncology, Inc., NUVASIVE INC, Alliqua BioMedical, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, ALIMERA SCIENCES INC, OTONOMY, INC., NOVACEA INC, REVA Medical, Inc., SENOMYX INC, CADENCE PHARMACEUTICALS INC, Achaogen Inc, Regado Biosciences Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, SANTARUS INC, Somaxon Pharmaceuticals, Inc., SENORX INC, Northstar Neuroscience, Inc., IOMAI CORP, INTRALASE CORP, and PHARMION CORP.

SEC CIK

James C Blair's CIK is 0001024000

Past Insider Trading and Trends

2007 was James C Blair's most active year for acquiring shares with 9 total transactions. James C Blair's most active month to acquire stocks was the month of May. 2007 was James C Blair's most active year for disposing of shares, totalling 5 transactions. James C Blair's most active month to dispose stocks was the month of February. 2019 saw James C Blair paying a total of $114,000.00 for 69,404 shares, this is the most they've acquired in one year. In 2008 James C Blair cashed out on 50,066 shares for a total of $0.00, their largest year based on trade value.